| Form |
Filed |
Description |
|
| 144 |
May 30, 2024 |
|
|
| 144 |
May 30, 2024 |
|
|
| 144 |
May 30, 2024 |
|
|
| 10-Q |
May 6, 2024 |
10-Q |
|
| 8-K |
May 6, 2024 |
FORM 8-K |
|
| ARS |
Apr 25, 2024 |
ARS |
|
| DEF 14A |
Apr 25, 2024 |
DEF 14A |
|
| 8-K |
Mar 1, 2024 |
FORM 8-K |
|
| 424B5 |
Mar 1, 2024 |
424B5 |
|
| 424B5 |
Feb 28, 2024 |
424B5 |
|
| 424B5 |
Feb 26, 2024 |
424B5 |
|
| 10-K |
Feb 26, 2024 |
10-K |
|
| 8-K |
Feb 26, 2024 |
FORM 8-K |
|
| 4 |
Feb 15, 2024 |
|
|
| SC 13G/A |
Feb 14, 2024 |
CELLDEX THERAPEUTICS, INC. |
|
| SC 13G |
Feb 14, 2024 |
KYNAM CAPITAL MANAGEMENT, LP |
|
| SC 13G |
Feb 14, 2024 |
SC 13G |
|
| SC 13G/A |
Feb 14, 2024 |
CELLDEX THERAPEUTICS, INC. |
|
| SC 13G/A |
Feb 13, 2024 |
SCHEDULE 13G/A |
|
| SC 13G |
Feb 13, 2024 |
|
|
| SC 13G/A |
Feb 9, 2024 |
|
|
| SC 13G/A |
Feb 8, 2024 |
SEC SCHEDULE 13G |
|
| SC 13G/A |
Jan 26, 2024 |
|
|
| 4 |
Jan 4, 2024 |
|
|
| SC 13G |
Nov 20, 2023 |
CELLDEX THERAPEUTICS, INC. |
|
No filings match your search.
